Efficacy of aprotinin with various anticoagulant agents in cardiopulmonary bypass

This publication has 15 references indexed in Scilit:

• A Multicenter, Double-Blind, Placebo-Controlled Trial of Aprotinin for Reducing Blood Loss and the Requirement for Donor-Blood Transfusion in Patients Undergoing Repeat Coronary Artery Bypass Grafting
  Circulation, 1995
• Evaluation of CGP 39393 as the anticoagulant in cardiopulmonary bypass operation in a dog model
  The Annals of Thoracic Surgery, 1994
• Platelet adhesion to fibronectin in flow: dependence on surface concentration and shear rate, role of platelet membrane glycoproteins GP IIb/IIIa and VLA-5, and inhibition by heparin
  Blood, 1994
• Reduction of heparin binding to and inhibition of platelets by aprotinin
  The Annals of Thoracic Surgery, 1993
• Evaluation of a low molecular weight heparin as an anticoagulant in a model of cardiopulmonary bypass surgery
  Thrombosis Research, 1993
• Effects of aprotinin on anticoagulant monitoring: Implications in cardiovascular surgery
  The Annals of Thoracic Surgery, 1993
• Aprotinin therapy for reoperative myocardial revascularization: A placebo-controlled study
  The Annals of Thoracic Surgery, 1992
• Aprotinin can inhibit the proteolytic activity of thrombin
  European Journal of Biochemistry, 1992
• Effect of heparin and enoxaparin on platelet interaction with fibrin clots
  Thrombosis Research, 1992
• Aprotinin (Trasylol) is a competitive inhibitor of activated protein C
  Thrombosis Research, 1989